TP53 and central nervous system cancer: In this study, co-occurring mutations and copy number alterations of 35 associated genes in the MAPK and p53 pathways were retrieved and investigated, and the prognosis of the available adult glioma cohorts with BRAFV600E and BRAFnon-V600E were evaluated by using The Cancer Genome Atlas (TCGA) public database.